Evogene | EVGN - Cash And Equivalent

Stock Price
315.50
Daily Change
1.90 0.61%
Monthly
-11.67%
Yearly
-40.92%
Q1 Forecast
309.23

Evogene reported $5.63M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
CVR Partners USD 156.18M 41.78M Sep/2025
Evogene USD 5.63M 2.7M Sep/2025
Hawkins USD 8.21M 2.21M Dec/2025
Innospec USD 270.8M 4.2M Sep/2025
Koppers USD 37.9M 500K Sep/2025
Kronos Worldwide USD 27.7M 8.8M Sep/2025
Materion USD 16.41M 3.82M Sep/2025
Minerals Technologies USD 329M 9.4M Dec/2025
Rayonier Advanced Materials USD 77.03M 6.03M Sep/2025
Sensient Technologies USD 42.67M 14.02M Sep/2025
Stepan USD 118.5M 29.6M Sep/2025
Tronox USD 185M 53M Sep/2025
Valhi USD 183.5M 5M Sep/2025
WD-40 USD 58.13M 6.45M Jun/2025